Characterization of the acetylcholine-reducing effect of the amyloid-β peptide in mouse SN56 cells

Neuroscience Letters

Volumn 239, Issue 2-3, 1997, Pages 77-80

  Pedersen, Ward A ^a   Blusztajn, Jan K ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Basal forebrain; Cholinergic; Neurotransmitter; Septum

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; APHIDICOLIN; DNA; GENISTEIN; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA SYNTHESIS INHIBITION; FOREBRAIN; MOUSE; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE;

ACETYLCHOLINE; AMYLOID BETA-PROTEIN; ANIMALS; APHIDICOLIN; CELL LINE; ENZYME INHIBITORS; GENISTEIN; HIPPOCAMPUS; MICE; NITRILES; PEPTIDE FRAGMENTS; PROTEIN-TYROSINE KINASES; TYRPHOSTINS; VITAMIN E;

EID: 0031578891     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00913-0     Document Type: Article

References (23)

1. Behl C., Davis J.B., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186:1992;944-952.
2. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β toxicity. Cell. 77:1994;817-827.
3. Dutar P., Bassant M.-H., Senut M.-C., Lamour Y. The septohippocampal pathway: structure and function of a central cholinergic system. Physiol. Rev. 75:1995;393-427.
4. Etcheberrigaray R., Ito E., Oka K., Tofel-Grehl B., Gibson G.E., Alkon D.L. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8209-8213.
5. + channels. Science. 264:1994;276-279.
6. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebro-vascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
7. Glicksman M.A., Forbes M.E., Prantner J.E., Neff N.T. K-252a promotes survival and choline acetyltransferase activity in striatal and basal forebrain neuronal cultures. J. Neurochem. 64:1995;1502-1512.
8. Hoshi M., Takashima A., Murayama M., Yasutake K., Yoshida N., Ishiguro K., Hoshino T., Imahori K. Nontoxic amyloid β peptide 1-42 suppresses acetylcholine synthesis. J. Biol. Chem. 272:1997;2038-2041.
9. Iversen L.L., Mortishire-Smith R.J., Pollack S.J., Shearman M.S. The toxicity in vitro of β-amyloid protein. Biochem. J. 311:1995;1-16.
10. Kar S., Seto D., Gaudreau P., Quirion R. β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 16:1996;1034-1040.
11. Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M., Roth G.S., Mattson M.P. Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA. 93:1996;6753-6758.
12. Kuo Y.-M., Emmerling M.R., Vigo-Pelfrey C., Kasunic T.C., Kirkpatrick J.B., Murdoch G.H., Ball M.J., Roher A.E. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271:1996;4077-4081.
13. Luo Y.Q., Hirashima N., Li Y.H., Alkon D.L., Sunderland T., Etcheberrigaray R., Wolozin B. Physiological levels of β-amyloid increase tyrosine phosphorylation and cytosolic calcium. Brain Res. 681:1995;65-74.
14. Luo Y., Sunderland T., Wolozin B. Physiologic levels of β-amyloid activate phosphatidylinositol 3-kinase with the involvement of tyrosine phosphorylation. J. Neurochem. 67:1996;978-987.
15. Luo Y., Sunderland T., Roth G.S., Wolozin B. Physiological levels of β-amyloid peptide promote PC12 cell proliferation. Neurosci. Lett. 217:1996;125-128.
16. Mattson, M.P., Furukawa, K., Bruce, A.J., Mark, R.J. and Blanc, E., Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. In W. Wasco and R.E. Tanzi (Eds.), Molecular Mechanisms of Dementia, Humana Press, Totowa, NJ, 1996, 312 pp.
17. Pedersen W.A., Berse B., Schuler U., Wainer B.H., Blusztajn J.K. All-trans- and 9-cis-retinoic acid enhance the cholinergic properties of a murine septal cell line: evidence that the effects are mediated by activation of retinoic acid receptor-α J. Neurochem. 65:1995;50-58.
18. Pedersen W.A., Kloczewiak M.A., Blusztajn J.K. Amyloid-β protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. USA. 93:1996;8068-8071.
19. Selkoe D.J. Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
20. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D.J., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-327.
21. Urbani L., Sherwood S.W., Schimke R.T. Dissociation of nuclear and cytoplasmic cell cycle progression by drugs employed in cell synchronization. Exp. Cell Res. 219:1995;159-168.
22. van Gool W.A., Schenk D.B., Bolhuis P.A. Concentrations of amyloid-β protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease. Neurosci. Lett. 172:1994;122-124.
23. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.